Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes—implications for cost-effectiveness analyses

Irene GM van Valkengoed,1,2 Servaas A Morré,3,4 Adriaan JC van den Brule,3,5 Chris JLM Meijer,3 Lex M Bouter1 and A Joan P Boeke1
International Journal of Epidemiology 2004;33:416–425 DOI: 10.1093/ije/dyh029